Dasha Pharmaceuticals plans to set up Pharmaceutical Ingredients Manufacturing Unit in Maharashtra

Dasha Pharmaceuticals Private Limited has begun work on a new Active Pharmaceutical Ingredients (API) Project in Chincholi, Solapur, Maharashtra. Although the project is still in the planning stages, it is estimated to cost 40 crores. The new plant will be outfitted with cutting-edge machinery and technology to manufacture high-quality APIs. The APIs will be used in a wide range of pharmaceutical goods, such as medications, vaccines, and diagnostic tests. The project is projected to stimulate the local economy and offer new job possibilities.

 The project will also assist India in meeting its expanding demand for high-quality APIs. Here are some of the benefits of the Dasha Pharmaceuticals Private Limited new API Project: It will create jobs and boost the local economy. It will help India meet its growing demand for high-quality APIs. It will use state-of-the-art machinery and technology to produce high-quality APIs. The APIs will be used in a variety of pharmaceutical products, including drugs, vaccines, and diagnostic kits. The project is expected to have a positive impact on the environment as well. 

The new plant will be equipped with pollution control measures to minimize its environmental impact. Dasha Pharmaceuticals Private Limited new API Project is a positive development that is expected to benefit the local community, the Indian economy, and the environment.

As of September 2023, The project is now in the stage of receiving approvals & has obtained all necessary government permissions work of the project is anticipated to occur in either 2023 or 2024.

News by Rahul Yeligetti